GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Current Deferred Revenue

Genetron Holdings (Genetron Holdings) Current Deferred Revenue : $3.88 Mil (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Genetron Holdings's current deferred revenue for the quarter that ended in Jun. 2022 was $3.88 Mil.

Genetron Holdings Current Deferred Revenue Historical Data

The historical data trend for Genetron Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Current Deferred Revenue Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Deferred Revenue
Get a 7-Day Free Trial 1.29 2.59 4.31 4.23 3.16

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.96 4.23 1.37 3.88 3.16

Genetron Holdings Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Current Deferred Revenue
Comparable Companies
BNR BDSX FONR PRPH ENZ LAB PRE VNRX SERA BIOQ TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Website
https://www.genetronhealth.com
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.